Pituitary Gland Stimulation for Cancer Pain Relief

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT06354049` - Reiki Therapy to Improve Key Symptoms in Integrative Oncology Clinic (REIKI)	N/A
Active, not recruiting	`NCT05663346` - Cannabis and Cancer, an Online Training for Oncology Nurses	N/A
Recruiting	`NCT04737967` - The Potential Protective Role of Venlafaxine Versus Memantine in Paclitaxel Induced Peripheral Neuropathy	Phase 2/Phase 3
Recruiting	`NCT04931745` - Virtual Reality for Port-a-Cath Access	N/A

See also

Status

Clinical Trial

Phase

Not yet recruiting

NCT06354049 - Reiki Therapy to Improve Key Symptoms in Integrative Oncology Clinic (REIKI)

N/A

Active, not recruiting

NCT05663346 - Cannabis and Cancer, an Online Training for Oncology Nurses

N/A

Recruiting

NCT04737967 - The Potential Protective Role of Venlafaxine Versus Memantine in Paclitaxel Induced Peripheral Neuropathy

Phase 2/Phase 3

Recruiting

NCT04931745 - Virtual Reality for Port-a-Cath Access

N/A

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT05230238
Study type	Interventional
Source	Leiden University Medical Center
Contact	Wouter van Furth, MD, Phd
Phone	+31715162109
Email	w.r.van_furth@lumc.nl
Status	Recruiting
Phase	N/A
Start date	October 12, 2021
Completion date	January 1, 2024

Pituitary Gland Stimulation for Cancer Pain Relief — PGS

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms